Skip to main content
SpringerLink
Log in

Hepatotoxicity with anticom ulsant drugs: is routine laboratory monitoring useful?

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bryant AE, Dreifuss FE. Hepatotoxicity associated with antiepileptic drug therapy: avoidance identification and management. CNS Drugs 1995; 4(2): 99–113

    Article  CAS  Google Scholar 

  2. KÖnig St A, Siemes H, Bläker F, et al. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 1994; 35: 1005–15

    Article  PubMed  Google Scholar 

  3. Wall M, Baird-Lambert J, Buchanan N, et al. Liver function tests in persons receiving anticonvulsant medications. Seizure 1992; 1: 187–90

    Article  PubMed  CAS  Google Scholar 

  4. Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991; 41: 961–4

    Article  PubMed  CAS  Google Scholar 

  5. Wyllie E, Wyllie R. Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy. Epilepsia 1991; 32 Suppl. 5: S74–9

    PubMed  Google Scholar 

  6. Camfield P, Camfield C, Dooley J, et al. Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful value. Can Med Assoc J 1989; 140: 1303–5

    CAS  Google Scholar 

  7. 1995 Physicians GenRx. St. Louis, Missouri: Mosby-Year Book, Inc. 1995

  8. ABPI data sheet compendium, 1995/96. London: Datapharma Publications Ltd, 1995; 1559–61

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepatotoxicity with anticom ulsant drugs: is routine laboratory monitoring useful?. Drugs Ther. Perspect 6, 14–16 (1995). https://doi.org/10.2165/00042310-199506110-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506110-00006

Search

Navigation